Picture of Montvale Technologies logo

IVVI Montvale Technologies Share Price

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Momentum

Relative Strength (%)
1m-1.54%
3m-99.03%
6m-99.09%
1yr-16.07%
Volume Change (%)
10d/3mn/a
Price vs... (%)
52w Highn/a
50d MAn/a
200d MAn/a

Growth & Value

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capitaln/a
Return on Equity-286.58%
Operating Margin-661.27%

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 201031st Mar 2011
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2010 / 2011

Blurred out image of Montvale Technologies EPS forecast chart

Profile Summary

Montvale Technologies, Inc., formerly Ivivi Technologies, Inc., is an early stage medical technology company focusing on designing, developing and commercializing electrotherapeutic technologies. The Company has focused its research and development activities on targeted pulsed electromagnetic field (tPEMF) technology. The Company is marketing products utilizing its tPEMF technology to various surgery markets for adjunctive use in the treatment of post operative pain and edema in superficial soft tissue. The Company is developing technology for other therapeutic medical markets.

Directors

Last Annual
March 31st, 2009
Last Interim
September 30th, 2009
Incorporated
March 9th, 1989
Public Since
October 19th, 2006
No. of Shareholders
33
No. of Employees
15
Sector
Healthcare Equipment & Supplies
Industry
Healthcare
Exchange
us flag iconPink Sheets on Nasdaq
Shares in Issue
11,241,033
Blurred out image of a map
Address
224s Pegasus Ave, NORTHVALE, 07647-1904
Web
Phone
+1 2014769600
Auditors
Raich Ende Malter Lerner & Co.

IVVI Share Price Performance

Similar to IVVI

Picture of Aamaxan Transport logo

Aamaxan Transport

us flag iconPink Sheets on Nasdaq

Picture of ACCUSTEM SCIENCES logo

ACCUSTEM SCIENCES

us flag iconPink Sheets on Nasdaq

Picture of Acutus Medical logo

Acutus Medical

us flag iconPink Sheets on Nasdaq

Picture of ADM Tronics Unlimited logo

ADM Tronics Unlimited

us flag iconPink Sheets on Nasdaq

FAQ